Does the Development of Vaccines Advance Solutions for Tuberculosis?
BACKGROUND: Mycobacterium tuberculosis (Mtb) is considered as one of the most efficacious human pathogens. The global mortality rate of TB stands at approximately 2 million, while about 8 to 10 million active new cases are documented yearly. It is, therefore, a priority to develop vaccines that will...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bentham Science
2018
|
| Subjects: | |
| Online Access: | http://umpir.ump.edu.my/id/eprint/23655/ http://umpir.ump.edu.my/id/eprint/23655/ http://umpir.ump.edu.my/id/eprint/23655/ http://umpir.ump.edu.my/id/eprint/23655/1/Does%20the%20Development%20of%20Vaccines%20Advance%20Solutions%20for%20Tuberculosis.pdf |